New ALS drug trial hopes to slow nerve damage
Disease control
Recruiting now
This study tests an experimental drug called NB-4746 in 80 people with ALS. The goal is to see if it is safe, how it moves through the body, and whether it can reduce a marker of nerve damage (NfL) in the blood. Participants are randomly assigned to receive either NB-4746 or a pl…
Phase: PHASE1, PHASE2 • Sponsor: Nura Bio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC